Molecular biology of cervical cancer

被引:42
作者
Martin, A. Gonzalez [1 ]
机构
[1] Univ Hosp Ramon & Cajal, Med Oncol Serv, ES-28034 Madrid, Spain
关键词
cervical cancer; human papilloma virus; carcinogenesis; new targets;
D O I
10.1007/s12094-007-0066-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Cervical cancer is a virus-induced disease that is caused by the integration of high-risk infecting human papillomaviruses (HPV) in the host genome. For this reason, the carcinogenesis process of cervical cancer is associated to the expression of the viral oncogenic proteins E6 and E7. These proteins are capable of inactivating p53 and pRb, which induces a continuous cell proliferation with the increasing risk of accumulation of DNA damage that eventually leads to cancer. Moreover, cervical cancer can be prevented by prophylactic HPV vaccines; their molecular characteristics and mechanism of action are reviewed. Ultimately, new molecular targets for cervical cancer like proteasome, the EGFR family and IGF family are exposed.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 57 条
[1]
The proteasome: A suitable antineoplastic target [J].
Adams, J .
NATURE REVIEWS CANCER, 2004, 4 (05) :349-360
[2]
The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors [J].
Antinore, MJ ;
Birrer, MJ ;
Patel, D ;
Nader, L ;
McCance, DJ .
EMBO JOURNAL, 1996, 15 (08) :1950-1960
[3]
STRUCTURAL AND TRANSCRIPTIONAL ANALYSIS OF HUMAN PAPILLOMAVIRUS TYPE-16 SEQUENCES IN CERVICAL-CARCINOMA CELL-LINES [J].
BAKER, CC ;
PHELPS, WC ;
LINDGREN, V ;
BRAUN, MJ ;
GONDA, MA ;
HOWLEY, PM .
JOURNAL OF VIROLOGY, 1987, 61 (04) :962-971
[4]
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells [J].
Bousarghin, L ;
Touzé, A ;
Sizaret, PY ;
Coursaget, P .
JOURNAL OF VIROLOGY, 2003, 77 (06) :3846-3850
[5]
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth [J].
Brehm, A ;
Nielsen, SJ ;
Miska, EA ;
McCance, DJ ;
Reid, JL ;
Bannister, AJ ;
Kouzarides, T .
EMBO JOURNAL, 1999, 18 (09) :2449-2458
[6]
Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. [J].
Clifford, GM ;
Rana, RK ;
Franceschi, S ;
Smith, JS ;
Gough, G ;
Pimenta, JM .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) :1157-1164
[7]
Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Plummer, M ;
Muñoz, N ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73
[8]
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses [J].
Combita, AL ;
Touzé, A ;
Bousarghin, L ;
Christensen, ND ;
Coursaget, P .
JOURNAL OF VIROLOGY, 2002, 76 (13) :6480-6486
[9]
Kinetics of in vitro adsorption and entry of papillomavirus virions [J].
Culp, TD ;
Christensen, ND .
VIROLOGY, 2004, 319 (01) :152-161
[10]
The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains [J].
Day, PM ;
Roden, RBS ;
Lowy, DR ;
Schiller, JT .
JOURNAL OF VIROLOGY, 1998, 72 (01) :142-150